Discover how NeXT Personal's liquid biopsy revolutionizes early lung cancer detection by analyzing ctDNA.

A groundbreaking study from the University of St Andrews School of Medicine has shown that biomarker testing in individuals at high risk for lung...

Circulating tumour DNA (ctDNA) is fragments of DNA released into the blood by tumours. It’s known to be important for disease prognosis but can be...

TriOx, a novel blood test shows potential in detecting cancer among six cancer types including medlinkcolorectal/medlink, medlinkesophageal/medlink,

Circulating tumor DNA test enables early detection of leptomeningeal disease in diffuse midline gliomas

Discover how the TriOx blood test uses DNA analysis and machine learning to detect six types of cancer early, offering a fast and accurate method.

Researchers at the Francis Crick Institute, the UCL Cancer Institute, and UCLH have shown that a test called ORACLE can predict lung cancer survival...

Lung-sparing surgery could enhance outcomes for early-stage lung cancer patients by preserving lung function while effectively treating the disease.